Les bases moléculaires de l'obésité : vers de nouvelles thérapeutiques ?

Détails

ID Serval
serval:BIB_1C591C5BB8D6
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Les bases moléculaires de l'obésité : vers de nouvelles thérapeutiques ?
Périodique
Medecine Sciences
Auteur⸱e⸱s
Michalik L., Desvergne B., Wahli W.
ISSN
0767-0974
Statut éditorial
Publié
Date de publication
2000
Peer-reviewed
Oui
Volume
16
Numéro
10
Pages
1030-1039
Langue
français
Notes
[Obesity: Molecular basis and therapeutic targets]
Résumé
Obesity is an increasingly serious health problem, and is highly associated with insulin-resistance and dyslipidemia. The mechanisms involved in the development of this disorder are still poorly understood, although significant progress has been recently made in the elucidation of their molecular basis. The major causes leading to obesity are defects in the regulation of fat metabolism. Several mutations identified in different animal models have unveiled the roles of a number of genes in the regulation of energy balance. These dicoveries, together with the fact that some of these mutations have been found in humans, have lead to the conclusion that obesity is due to nutritional or environmental factors, but also involves genetic factors. A number of important peripheric factors participate in the regulation processes, such as the adipocyte-specific hormone leptin, and the nuclear homone receptors PPARs. A general scheme can now be drawn which includes some key factors and their respective interactions.
Mots-clé
leptin (endogenous compound), peroxisome proliferator activated receptor (endogenous compound), cell nucleus receptor (endogenous compound), hormone receptor (endogenous compound), tumor necrosis factor alpha (endogenous compound), uncoupling protein 1 (endogenous compound), uncoupling protein 2 (endogenous compound), uncoupling protein 3 (endogenous compound), obesity (etiology) , adipocyte, disease association, dyslipidemia, energy balance, environmental factor, gene mutation, heredity, human, insulin resistance, lipid metabolism, nonhuman, nutrition, review
Web of science
Création de la notice
24/01/2008 15:44
Dernière modification de la notice
20/08/2019 12:52
Données d'usage